Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
Factors Associated With the Absence of Contraception at the Time of Unplaned Pregnancy Among Women Seeking a Voluntary Termination of Pregnancy
Descripción general del estudio
Estado
Condiciones
Descripción detallada
In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed.
Contraceptive coverage is important in France as it is estimated that 92% of women of childbearing age use a contraceptive method. The pill remains the most widely used method of contraception (36.5%), ahead of the intrauterine device (25.6%) condoms (15.5%) Several laws have been introduced from 1967 to today to facilitate access to sexual health care: screening for sexually transmitted infections, free provision of emergency contraception to minors, non-prescription delivery of emergency contraception, free consultation at a family planning and education center, voluntary termination of pregnancy 100%, reimbursement of condoms by social security.
Despite all the measures put in place, it is now clear that the number of unplanted pregnancies is decreasing slightly and the number of abortion has remained stable since 2001.
According to the latest literature data, several socio-demographic factors appear to play a role in the rate of use of voluntary termination of pregnancy., including age, socio-cultural level, marital and economic status and ethnic origin. All the more striking, it appears that while voluntary termination of pregnancy are mainly related to contraceptive failures, one third of them involve women who do not have contraception. According to the latest Ined survey, and in accordance with other data from the literature, the factors associated with the absence of contraceptive use are multiple: ignorance about fertility, family or cultural context, cost of contraceptive methods or lack of information related to them.
While these studies have looked at the reasons given by women for the lack of contraception, with little data on the characteristics of these women, particularly socio-demographics and their reproductive history and in particular in the context of unwanted pregnancy. This finding leads us to question the factors associated with the absence of contraception among women in demand of a voluntary termination of pregnancy.
Tipo de estudio
Inscripción (Anticipado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Villeneuve-Saint-Georges, Francia
- CHI Villeneuve St Georges
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- woman of 18 years of age or older;
- Being French-speaking;
- request for a medical or instrumental voluntary termination of pregnancy
- No opposition to participation in the protocol
- Be affiliated with a social security plan
Exclusion Criteria:
- desired pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Association between absence of contraception and socio-demographic factors, characteristics of pregnancy abortion and medical follow-up
Periodo de tiempo: 1 hour
|
Statistically significant association between the absence of contraception in patients consulting for a voluntary termination of pregnancy and socio-demographic factors, characteristics of voluntary termination of pregnancy abortion and characteristics related to medical follow-up
|
1 hour
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Prescription and dispensing of contraception
Periodo de tiempo: 1 hour
|
Prevalence of patients informed about the prescription and dispensing of contraception including emergency contraception
|
1 hour
|
|
Existence of family planning centers
Periodo de tiempo: 1 hour
|
Prevalence of patients informed about the existence of family planning centers
|
1 hour
|
|
Emergency contraception
Periodo de tiempo: 1 hour
|
Prevalence of women who have used emergency contraception
|
1 hour
|
|
Price and reimbursement of condoms
Periodo de tiempo: 1 hour
|
Prevalence of women informed about the price and reimbursement of condoms
|
1 hour
|
|
Knowledge of conception
Periodo de tiempo: 1 hour
|
Estimate the percentage of women who thought they could get pregnant at the time of the intercourse that led to this pregnancy
|
1 hour
|
|
Fertile window
Periodo de tiempo: 1 hour
|
Prevalence of women who use a method to track their fertile window
|
1 hour
|
|
Affection of fertility
Periodo de tiempo: 1 hour
|
Estimate the percentage of women who think that contraception can affect their fertility
|
1 hour
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- NOCONTRAIVG
- 2021-A00298-33 (Otro identificador: ID-RCB)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .